Atara Biotherapeutics Inc (ATRA): Next-Year EPS Estimate 236.15%
As of 2026-10-23, Atara Biotherapeutics Inc (ATRA) has a next-year EPS growth estimate of 236.15%. Featured in our EPS revision report on 2026-09-08.
On 2026-08-31, analyst consensus for ATRA's next-year EPS growth shifted from 156.43% to 236.15% — a positive change of 79.72 percentage points. The revised estimate has been sustained across 48 subsequent trading sessions. Current-year growth is projected at -126.90%.
What's Driving This
ATRA has been rising primarily because analysts sharply raised the next-year EPS growth
Generated 2026-10-23 from news as of 2026-10-23
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 236.15%
- EPS growth this year
- -126.90%
- EPS next quarter (est)
- -$0.13
- Last price
- $8.59
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-10-23 | 236.15% | -126.90% | -$0.13 | $8.59 |
| 2026-10-22 | 236.15% | -126.90% | -$0.13 | $9.43 |
| 2026-10-21 | 236.15% | -126.90% | -$0.13 | $9.35 |
| 2026-10-20 | 236.15% | -126.90% | -$0.13 | $9.16 |
| 2026-10-19 | 236.15% | -126.90% | -$0.13 | $8.96 |
| 2026-10-16 | 236.15% | -126.90% | -$0.13 | $9.18 |
| 2026-10-15 | 236.15% | -126.90% | -$0.13 | $9.65 |
| 2026-10-14 | 236.15% | -126.90% | -$0.13 | $9.56 |
| 2026-10-13 | 236.15% | -126.90% | -$0.13 | $9.31 |
| 2026-10-12 | 236.15% | -126.90% | -$0.13 | $9.38 |
| 2026-10-11 | 236.15% | -126.90% | -$0.13 | $9.48 |
| 2026-10-10 | 236.15% | -126.90% | -$0.13 | $9.48 |
| 2026-10-09 | 236.15% | -126.90% | -$0.13 | $9.48 |
| 2026-10-08 | 236.15% | -126.90% | -$0.13 | $9.23 |
| 2026-10-07 | 236.15% | -126.90% | -$0.13 | $9.37 |
| 2026-10-06 | 236.15% | -126.90% | -$0.13 | $9.75 |
| 2026-10-05 | 236.15% | -126.90% | -$0.13 | $9.40 |
| 2026-10-04 | 236.15% | -126.90% | -$0.13 | $9.48 |
| 2026-10-03 | 236.15% | -126.90% | -$0.13 | $9.48 |
| 2026-10-02 | 236.15% | -126.90% | -$0.13 | $9.48 |
| 2026-10-01 | 236.15% | -126.90% | -$0.13 | $8.46 |
| 2026-09-30 | 236.15% | -126.90% | -$0.13 | $8.50 |
| 2026-09-29 | 236.15% | -126.90% | -$0.13 | $8.05 |
| 2026-09-28 | 236.15% | -126.90% | -$0.13 | $8.37 |
| 2026-09-27 | 236.15% | -126.90% | -$0.13 | $8.81 |
| 2026-09-25 | 236.15% | -126.90% | -$0.13 | $8.81 |
| 2026-09-24 | 236.15% | -126.90% | -$0.13 | $8.54 |
| 2026-09-23 | 236.15% | -126.90% | -$0.13 | $8.56 |
| 2026-09-22 | 236.15% | -126.90% | -$0.13 | $8.93 |
| 2026-09-21 | 236.15% | -126.90% | -$0.13 | $9.38 |
Reports Featuring ATRA
Recent News
- Atara Biotherapeutics: Q1 Earnings SnapshotAssociated Press
- Atara Biotherapeutics Announces First Quarter 2026 Financial Results and Operational ProgressBusiness Wire
- FDA Resubmission Path for Tab-cel Keeps Ataras (ATRA) Regulatory Timeline AliveInvestorsHub
- FDA Resubmission Path for Tab-cel Keeps Ataras (ATRA) Regulatory Timeline AliveInvestorsHub
- BC-Most Active StocksAssociated Press
- Atara Biotherapeutics Provides Regulatory Update on TabelecleucelBusiness Wire
- Atara Biotherapeutics Provides Regulatory Update on TabelecleucelBusiness Wire
Screen Performance
Aggregate stats across all 2095 tickers our top-EPS-revision screen has flagged over the past 205 days.
- Median return since detection
- -2.6%
- % of tickers in the green
- 44%
- Median return on winners
- +22.6%
- Large revisions captured
- 1936
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is Atara Biotherapeutics Inc's next-year EPS growth estimate?▾
As of 2026-10-23, Atara Biotherapeutics Inc (ATRA) has a next-year EPS growth estimate of 236.15%, based on analyst consensus.
When was the latest EPS estimate revision for ATRA?▾
The most recent revision occurred on 2026-08-31, when analysts adjusted the next-year EPS growth estimate from 156.43% to 236.15%.
What sector and industry does Atara Biotherapeutics Inc belong to?▾
Atara Biotherapeutics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. ATRA appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Atara Biotherapeutics Inc (ATRA) appears here because it was detected by our daily top-EPS-revision-performer screen.